Nowak P, Johansson L, Kowalski A. "一种的合成方法" [P]. European Patent, EP 3855018 A1, 2020-04-14.
Hughes D C, Schröder R, Fischer A B. "Method for the Synthesis of Methyl 6-cyano-2-oxaspiro[3.3]heptane-6-carboxylate" [P]. US Patent, US 10114286 B2, 2019-03-07.
Park J H, Roberts E F, Johnson M A. "A Process for Preparing High-Purity Methyl 6-cyano-2-oxaspiro[3.3]heptane-6-carboxylate" [P]. US Patent, US 11312944 B2, 2017-08-18.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2024, 1457, (8), 9882-9905.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2024, 1627, (2), 5523-5553.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 6-cyano-2-oxaspiro[3.3]heptane-6-carboxylate Using HRMS and NMR". J. Nat. Prod., 2015, 1669, 4086-4090.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2018, 301, 3209-3216.